$PRPO
Precipio, Inc.

2014 Q2 Form 10-Q Financial Statement

#000104396114000006 Filed on May 15, 2014

View on sec.gov

Income Statement

Concept 2014 Q2 2014 Q1 2013 Q1
Revenue $6.764M $6.251M $7.374M
YoY Change -7.42% -15.23% 2.33%
Cost Of Revenue $4.371M $3.757M $4.119M
YoY Change 0.88% -8.79% 0.41%
Gross Profit $2.393M $2.494M $3.255M
YoY Change -19.51% -23.38% 4.86%
Gross Profit Margin 35.38% 39.9% 44.14%
Selling, General & Admin $5.563M $5.288M $6.311M
YoY Change 11.66% -16.21% 26.37%
% of Gross Profit 232.47% 212.03% 193.89%
Research & Development $785.0K $745.0K $764.0K
YoY Change -14.02% -2.49% 39.16%
% of Gross Profit 32.8% 29.87% 23.47%
Depreciation & Amortization $488.0K $493.0K $744.0K
YoY Change -28.97% -33.74% 45.03%
% of Gross Profit 20.39% 19.77% 22.86%
Operating Expenses $6.348M $6.033M $7.075M
YoY Change 7.68% -14.73% 27.64%
Operating Profit -$3.955M -$3.539M -$3.820M
YoY Change 35.35% -7.36% 56.62%
Interest Expense $50.00K -$130.0K $250.0K
YoY Change 0.0% -152.0% -192.59%
% of Operating Profit
Other Income/Expense, Net $0.00 $0.00 $53.00K
YoY Change -100.0% 165.0%
Pretax Income -$3.901M -$3.671M -$3.520M
YoY Change 35.78% 4.29% 30.76%
Income Tax -$8.000K $505.0K $66.00K
% Of Pretax Income
Net Earnings -$3.893M -$4.176M -$3.586M
YoY Change 35.79% 16.45% 33.01%
Net Earnings / Revenue -57.55% -66.81% -48.63%
Basic Earnings Per Share
Diluted Earnings Per Share -$194.5M -$209.0M -$179.5M
COMMON SHARES
Basic Shares Outstanding 7.354M shares 7.354M shares 88.23M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2014 Q2 2014 Q1 2013 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.190M $1.740M $7.730M
YoY Change -81.38% -77.49% -59.93%
Cash & Equivalents $1.191M $1.743M $7.729M
Short-Term Investments
Other Short-Term Assets $879.0K $693.0K $1.185M
YoY Change -18.84% -41.52% 15.27%
Inventory $4.009M $4.053M $4.783M
Prepaid Expenses
Receivables $7.298M $6.191M $7.897M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $13.38M $12.68M $21.59M
YoY Change -32.84% -41.28% -30.42%
LONG-TERM ASSETS
Property, Plant & Equipment $1.836M $1.909M $2.071M
YoY Change -14.64% -7.82% 10.39%
Goodwill $6.918M $6.918M $6.918M
YoY Change 0.0% 0.0% 7.42%
Intangibles $8.665M $8.899M $10.36M
YoY Change -12.84% -14.12% 34.73%
Long-Term Investments
YoY Change
Other Assets $295.0K $311.0K $453.0K
YoY Change -32.34% -31.35% 223.57%
Total Long-Term Assets $17.71M $18.04M $19.80M
YoY Change -8.91% -8.92% 22.65%
TOTAL ASSETS
Total Short-Term Assets $13.38M $12.68M $21.59M
Total Long-Term Assets $17.71M $18.04M $19.80M
Total Assets $31.09M $30.72M $41.40M
YoY Change -21.01% -25.8% -12.26%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.537M $2.661M $1.516M
YoY Change 102.35% 75.53% -3.25%
Accrued Expenses $2.040M $1.809M $2.826M
YoY Change -10.76% -35.99% -21.35%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $691.0K $0.00 $364.0K
YoY Change -4.95% -100.0% -94.1%
Total Short-Term Liabilities $9.761M $8.046M $9.494M
YoY Change 23.34% -15.25% -39.23%
LONG-TERM LIABILITIES
Long-Term Debt $6.211M $3.758M $6.069M
YoY Change -14.6% -38.08%
Other Long-Term Liabilities $1.897M $1.855M $1.266M
YoY Change 53.6% 46.52% 4.54%
Total Long-Term Liabilities $8.108M $5.613M $7.335M
YoY Change -4.7% -23.48% 505.7%
TOTAL LIABILITIES
Total Short-Term Liabilities $9.761M $8.046M $9.494M
Total Long-Term Liabilities $8.108M $5.613M $7.335M
Total Liabilities $20.74M $16.43M $17.33M
YoY Change 13.06% -5.22% -18.57%
SHAREHOLDERS EQUITY
Retained Earnings -$177.1M -$172.9M -$155.6M
YoY Change 11.66% 11.15% 6.79%
Common Stock $73.00K $73.00K $887.0K
YoY Change -91.77% -91.77% 23.02%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $10.35M $14.29M $24.07M
YoY Change
Total Liabilities & Shareholders Equity $31.09M $30.72M $41.40M
YoY Change -21.01% -25.8% -12.26%

Cashflow Statement

Concept 2014 Q2 2014 Q1 2013 Q1
OPERATING ACTIVITIES
Net Income -$3.893M -$4.176M -$3.586M
YoY Change 35.79% 16.45% 33.01%
Depreciation, Depletion And Amortization $488.0K $493.0K $744.0K
YoY Change -28.97% -33.74% 45.03%
Cash From Operating Activities -$3.390M -$3.866M -$3.334M
YoY Change 43.64% 15.96% 20.8%
INVESTING ACTIVITIES
Capital Expenditures -$60.00K $45.00K $87.00K
YoY Change -76.92% -48.28% -56.06%
Acquisitions
YoY Change
Other Investing Activities -$10.00K $48.00K $127.0K
YoY Change -66.67% -62.2% 89.55%
Cash From Investing Activities -$80.00K -$93.00K -$1.063M
YoY Change -73.33% -91.25% 301.13%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00 $7.570M
YoY Change -100.0% -56.7%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.910M $4.071M $7.668M
YoY Change 120.45% -46.91% -55.8%
NET CHANGE
Cash From Operating Activities -3.390M -$3.866M -$3.334M
Cash From Investing Activities -80.00K -$93.00K -$1.063M
Cash From Financing Activities 2.910M $4.071M $7.668M
Net Change In Cash -560.0K $112.0K $3.271M
YoY Change -58.21% -96.58% -77.16%
FREE CASH FLOW
Cash From Operating Activities -$3.390M -$3.866M -$3.334M
Capital Expenditures -$60.00K $45.00K $87.00K
Free Cash Flow -$3.330M -$3.911M -$3.421M
YoY Change 58.57% 14.32% 15.65%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
2661000 USD
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2860000 USD
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5314000 USD
CY2014Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6191000 USD
CY2013Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2037000 USD
CY2014Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1809000 USD
CY2014Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
13269000 USD
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
13126000 USD
CY2014Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
402000 USD
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
390000 USD
CY2013Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
179459000 USD
CY2014Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
186685000 USD
CY2013 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
360000 USD
CY2014Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
270000 USD
CY2013Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3838000 USD
CY2014Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3540000 USD
CY2012Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2171000 USD
CY2013Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2549000 USD
CY2013Q1 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
1203000 USD
CY2014Q1 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
971000 USD
CY2013Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
500000 USD
CY2014Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
300000 USD
CY2013Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2889033 shares
CY2014Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5523975 shares
CY2013Q4 us-gaap Assets
Assets
30278000 USD
CY2014Q1 us-gaap Assets
Assets
30717000 USD
CY2013Q1 us-gaap Assets
Assets
41398000 USD
CY2013Q4 us-gaap Assets Current
AssetsCurrent
11835000 USD
CY2014Q1 us-gaap Assets Current
AssetsCurrent
12680000 USD
CY2014Q1 us-gaap Capital Leases Income Statement Amortization Expense
CapitalLeasesIncomeStatementAmortizationExpense
100000 USD
CY2013Q1 us-gaap Capital Leases Income Statement Amortization Expense
CapitalLeasesIncomeStatementAmortizationExpense
100000 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1626000 USD
CY2014Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1743000 USD
CY2013Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7729000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4497000 USD
CY2013Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
3232000 USD
CY2014Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
117000 USD
CY2012Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
15.00
CY2012Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
823333 shares
CY2013Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
691656 shares
CY2014Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
2335348 shares
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2014Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2014Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2012Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2014Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7353695 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7353695 shares
CY2012Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1583333 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7353695 shares
CY2014Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7353695 shares
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
73000 USD
CY2014Q1 us-gaap Common Stock Value
CommonStockValue
73000 USD
CY2013Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3759000 USD
CY2014Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4164000 USD
CY2014Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3757000 USD
CY2013Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4119000 USD
CY2014Q1 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
3758000 USD
CY2013Q4 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
6560000 USD
CY2013Q1 us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
197000 USD
CY2014Q1 us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
0 USD
CY2013Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1088000 USD
CY2014Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1212000 USD
CY2014Q1 us-gaap Depreciation
Depreciation
100000 USD
CY2013Q1 us-gaap Depreciation
Depreciation
200000 USD
CY2014Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
493000 USD
CY2013Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
744000 USD
CY2014Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
2216000 USD
CY2013Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
1986000 USD
CY2014Q1 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
230000 USD
CY2013 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
726000 USD
CY2013Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.54
CY2014Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.60
CY2014Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
5000 USD
CY2013Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-39000 USD
CY2014Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.1376
CY2013Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1330000 USD
CY2014Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1296000 USD
CY2014Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
1900000 USD
CY2014Q1 us-gaap Fair Value Assumptions Expected Term
FairValueAssumptionsExpectedTerm
P3Y
CY2014Q1 us-gaap Fair Value Assumptions Expected Volatility Rate
FairValueAssumptionsExpectedVolatilityRate
0.50
CY2014Q1 us-gaap Fair Value Assumptions Risk Free Interest Rate
FairValueAssumptionsRiskFreeInterestRate
0.009
CY2014Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
4943000 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
4598000 USD
CY2014Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
1000000 USD
CY2014Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1300000 USD
CY2014Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1300000 USD
CY2014Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1300000 USD
CY2014Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
13842000 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
13793000 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
9195000 USD
CY2014Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
8899000 USD
CY2013Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
62000 USD
CY2014Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
0 USD
CY2013Q1 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
100000 USD
CY2014Q1 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-100000 USD
CY2014Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
0 USD
CY2013Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-9000 USD
CY2013Q4 us-gaap Goodwill
Goodwill
6918000 USD
CY2014Q1 us-gaap Goodwill
Goodwill
6918000 USD
CY2014Q1 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
57000 USD
CY2014Q1 us-gaap Gross Profit
GrossProfit
2494000 USD
CY2013Q1 us-gaap Gross Profit
GrossProfit
3255000 USD
CY2013Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3520000 USD
CY2014Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3671000 USD
CY2014Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
505000 USD
CY2013Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
66000 USD
CY2014Q1 us-gaap Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
400000 USD
CY2013Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-720000 USD
CY2014Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-203000 USD
CY2014Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1542000 USD
CY2013Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1474000 USD
CY2014Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-509000 USD
CY2013Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
0 USD
CY2014Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
149000 USD
CY2013Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-212000 USD
CY2013Q1 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
355000 USD
CY2014Q1 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-70000 USD
CY2014Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-263000 USD
CY2013Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
157000 USD
CY2013Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
9195000 USD
CY2014Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
8899000 USD
CY2014Q1 us-gaap Interest Paid
InterestPaid
157000 USD
CY2013Q1 us-gaap Interest Paid
InterestPaid
262000 USD
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
-4176000 USD
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
-3586000 USD
CY2013Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
2978000 USD
CY2014Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
3022000 USD
CY2014Q1 us-gaap Inventory Gross
InventoryGross
4902000 USD
CY2013Q4 us-gaap Inventory Gross
InventoryGross
4756000 USD
CY2014Q1 us-gaap Inventory Net
InventoryNet
4053000 USD
CY2013Q4 us-gaap Inventory Net
InventoryNet
3957000 USD
CY2013Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
799000 USD
CY2012Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
616000 USD
CY2014Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
849000 USD
CY2013Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
611000 USD
CY2014Q1 us-gaap Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
1641000 USD
CY2013Q4 us-gaap Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
1567000 USD
CY2014Q1 us-gaap Inventory Write Down
InventoryWriteDown
55000 USD
CY2013Q1 us-gaap Inventory Write Down
InventoryWriteDown
0 USD
CY2014Q1 us-gaap Liabilities
Liabilities
16425000 USD
CY2013Q4 us-gaap Liabilities
Liabilities
18832000 USD
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
30278000 USD
CY2014Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
30717000 USD
CY2014Q1 us-gaap Liabilities Current
LiabilitiesCurrent
8046000 USD
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
8625000 USD
CY2014Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
0 USD
CY2013Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
242000 USD
CY2014Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
3758000 USD
CY2013Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
6318000 USD
CY2014Q1 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
11304000 USD
CY2013Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
11255000 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4071000 USD
CY2013Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
7668000 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-93000 USD
CY2013Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1063000 USD
CY2013Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3334000 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3866000 USD
CY2013 us-gaap Net Income Loss
NetIncomeLoss
-15987000 USD
CY2013Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3767000 USD
CY2014Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4406000 USD
CY2014Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2013Q1 us-gaap Operating Expenses
OperatingExpenses
7075000 USD
CY2014Q1 us-gaap Operating Expenses
OperatingExpenses
6033000 USD
CY2014Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-3539000 USD
CY2013Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-3820000 USD
CY2014Q1 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
500000 USD
CY2014Q1 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
800000 USD
CY2014Q1 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
900000 USD
CY2014Q1 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
1000000 USD
CY2014Q1 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
900000 USD
CY2014Q1 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
800000 USD
CY2014Q1 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
200000 USD
CY2014Q1 us-gaap Other Assets Current
OtherAssetsCurrent
693000 USD
CY2013Q4 us-gaap Other Assets Current
OtherAssetsCurrent
938000 USD
CY2014Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
311000 USD
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
327000 USD
CY2013Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-173000 USD
CY2014Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
12000 USD
CY2013 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-45000 USD
CY2014Q1 us-gaap Other Inventory Demo
OtherInventoryDemo
239000 USD
CY2013Q4 us-gaap Other Inventory Demo
OtherInventoryDemo
211000 USD
CY2013Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1068000 USD
CY2014Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1068000 USD
CY2014Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1855000 USD
CY2013Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1303000 USD
CY2013Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
53000 USD
CY2014Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 USD
CY2013Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
127000 USD
CY2014Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
48000 USD
CY2013Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
60000 USD
CY2014Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0 USD
CY2012Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
1330000 USD
CY2014Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0 USD
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
744940 shares
CY2013Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
849000 USD
CY2014Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
45000 USD
CY2013Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
87000 USD
CY2013Q1 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
181000 USD
CY2014Q1 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
230000 USD
CY2014Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
230000 USD
CY2013Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
181000 USD
CY2014Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
15000000 shares
CY2014Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
15000000 shares
CY2014Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
4029502 shares
CY2013Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
2586205 shares
CY2014Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
4029502 shares
CY2013Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
2586205 shares
CY2014Q1 us-gaap Preferred Stock Value
PreferredStockValue
40000 USD
CY2013Q4 us-gaap Preferred Stock Value
PreferredStockValue
26000 USD
CY2014Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Reclassifications.</font></div><div style="line-height:120%;padding-top:18px;text-align:justify;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain prior period amounts of selling, general and administrative expenses have been reclassified to cost of goods sold in order to conform to the current period presentation. These reclassifications had no effect on previously reported net earnings</font></div></div>
CY2014Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
CY2013Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
7570000 USD
CY2014Q1 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
6970000 USD
CY2013Q1 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
0 USD
CY2014Q1 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
1400000 USD
CY2013Q1 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
6433000 USD
CY2014Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
15178000 USD
CY2013Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
15129000 USD
CY2014Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1909000 USD
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2003000 USD
CY2014Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
673000 USD
CY2013Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1581000 USD
CY2014Q1 us-gaap Purchase Commitment Remaining Minimum Amount Committed
PurchaseCommitmentRemainingMinimumAmountCommitted
1500000 USD
CY2013Q1 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
104000 USD
CY2014Q1 us-gaap Sales Revenue Net
SalesRevenueNet
6251000 USD
CY2013Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
6171000 USD
CY2014Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
4242000 USD
CY2014Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
745000 USD
CY2013Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
764000 USD
CY2014Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-172908000 USD
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-168502000 USD
CY2012Q1 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
12
CY2013Q1 us-gaap Sales Revenue Net
SalesRevenueNet
7374000 USD
CY2014Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5288000 USD
CY2013Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6311000 USD
CY2014Q1 us-gaap Share Based Compensation
ShareBasedCompensation
331000 USD
CY2013Q1 us-gaap Share Based Compensation
ShareBasedCompensation
164000 USD
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P3Y
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.0471
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.0577
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0172
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0078
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
25625 shares
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
199080 shares
CY2014Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
7353695 shares
CY2014Q1 tbio Accounts Receivable General Payment Terms
AccountsReceivableGeneralPaymentTerms
P30D
CY2014Q1 tbio Accounts Receivable International Extended Payment Terms Greater Than
AccountsReceivableInternationalExtendedPaymentTermsGreaterThan
P90D
CY2013Q1 us-gaap Share Price
SharePrice
6.00
CY2014Q1 us-gaap Share Price
SharePrice
4.58
CY2014Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
CY2014Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y3M14D
CY2013Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y6M18D
CY2013Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1383333 shares
CY2013 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
7570000 USD
CY2013Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
8300000 USD
CY2014Q1 us-gaap Stockholders Equity
StockholdersEquity
14292000 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
11446000 USD
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
20274000 USD
CY2014Q1 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.0833
CY2013 us-gaap Stockholders Equity Other
StockholdersEquityOther
0 USD
CY2014Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Use of Estimates.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of condensed consolidated financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of net sales and expenses during the reporting period. In addition, estimates and assumptions associated with the determination of the fair value of certain assets and related impairments require considerable judgment by management. Actual results could differ from the estimates and assumptions used in preparing these consolidated financial statements.</font></div></div>
CY2013Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
600000 USD
CY2014Q1 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
550000 USD
CY2013Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
7000292 shares
CY2014Q1 tbio Adjustment Of Warrants Granted
AdjustmentOfWarrantsGranted
-50000 USD
CY2013Q1 tbio Adjustment Of Warrants Granted
AdjustmentOfWarrantsGranted
-400000 USD
CY2012Q1 tbio Class Of Warrant Or Right Exercise Term
ClassOfWarrantOrRightExerciseTerm
P5Y
CY2013Q1 tbio Class Of Warrant Or Right Number Of Issued Warrants Or Rights
ClassOfWarrantOrRightNumberOfIssuedWarrantsOrRights
149272 shares
CY2013Q1 tbio Class Of Warrant Or Right Number Of Issued Warrants Or Rights
ClassOfWarrantOrRightNumberOfIssuedWarrantsOrRights
691656 shares
CY2013Q1 tbio Class Of Warrant Or Right Number Of Issued Warrants Or Rights
ClassOfWarrantOrRightNumberOfIssuedWarrantsOrRights
840928 shares
CY2014Q1 tbio Class Of Warrant Or Right Number Of Issued Warrants Or Rights
ClassOfWarrantOrRightNumberOfIssuedWarrantsOrRights
115432 shares
CY2013Q1 tbio Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights Price Per Share
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsPricePerShare
9.00
CY2014Q1 tbio Effective Tax Rate Reconciliation Permanent Differences Goodwill Amortization
EffectiveTaxRateReconciliationPermanentDifferencesGoodwillAmortization
500000 USD
CY2014Q1 tbio Fair Value Assumptions Percentage Of Simulated Equity Values Below Down Round Financing Cut Off Point
FairValueAssumptionsPercentageOfSimulatedEquityValuesBelowDownRoundFinancingCutOffPoint
0.25
CY2014Q1 tbio Finite Lived Intangible Assets Amortization Expense Current Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseCurrentFiscalYear
1400000 USD
CY2014Q1 tbio Furniture Fixtures And Leasehold Improvements Gross
FurnitureFixturesAndLeaseholdImprovementsGross
3874000 USD
CY2013Q4 tbio Furniture Fixtures And Leasehold Improvements Gross
FurnitureFixturesAndLeaseholdImprovementsGross
3874000 USD
CY2013Q1 tbio Interest Income And Expense Net
InterestIncomeAndExpenseNet
-153000 USD
CY2014Q1 tbio Interest Income And Expense Net
InterestIncomeAndExpenseNet
-182000 USD
CY2014Q1 tbio Inventory Provision Write Offs
InventoryProvisionWriteOffs
5000 USD
CY2013Q1 tbio Inventory Provision Write Offs
InventoryProvisionWriteOffs
5000 USD
CY2014Q1 tbio Issuance Of Warrants Expected Exercise Period
IssuanceOfWarrantsExpectedExercisePeriod
P2Y10M9D
CY2013Q1 tbio Other Income Expense
OtherIncomeExpense
300000 USD
CY2014Q1 tbio Other Income Expense
OtherIncomeExpense
-132000 USD
CY2014Q1 tbio Payments Of Stock Issuance Costs Reduction To Equity
PaymentsOfStockIssuanceCostsReductionToEquity
1500000 USD
CY2012Q1 tbio Paymentsof Stock Issuance Costs Percentageof Gross Offering Proceeds
PaymentsofStockIssuanceCostsPercentageofGrossOfferingProceeds
0.07
CY2012Q1 tbio Paymentsof Stock Issuance Costs Warrant Right To Purchase Common Stock Shares
PaymentsofStockIssuanceCostsWarrantRightToPurchaseCommonStockShares
31666 shares
CY2012Q1 tbio Paymentsof Stock Issuance Costs Warrant Right To Purchase Common Stock Shares Percentageof Sharesin Offering
PaymentsofStockIssuanceCostsWarrantRightToPurchaseCommonStockSharesPercentageofSharesinOffering
0.02
CY2014Q1 tbio Preferred Stock Issued During Period Value New Issues
PreferredStockIssuedDuringPeriodValueNewIssues
6970000 USD
CY2011Q4 tbio Proceedsfromissuanceofcommonstockandconvertiblenotes
Proceedsfromissuanceofcommonstockandconvertiblenotes
3000000 USD
CY2012Q1 tbio Proceedsfromissuanceofcommonstockandconvertiblenotes
Proceedsfromissuanceofcommonstockandconvertiblenotes
22000000 USD
CY2014Q1 tbio Provisionfor Doubtful Accounts Excluding Amounts Not Includedin Provision
ProvisionforDoubtfulAccountsExcludingAmountsNotIncludedinProvision
673000 USD
CY2013Q1 tbio Provisionfor Doubtful Accounts Excluding Amounts Not Includedin Provision
ProvisionforDoubtfulAccountsExcludingAmountsNotIncludedinProvision
1581000 USD
CY2014Q1 tbio Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Forfeiture Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate
0.01
CY2013Q1 tbio Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Forfeiture Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate
0.0407
CY2012Q1 tbio Stock Issuance Costs Reimbursable Expenses
StockIssuanceCostsReimbursableExpenses
125000 USD
CY2014Q1 tbio Stock Warrants Expense
StockWarrantsExpense
-50000 USD
CY2013Q1 tbio Stock Warrants Expense
StockWarrantsExpense
-400000 USD
CY2014Q1 dei Amendment Flag
AmendmentFlag
false
CY2014Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2014Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2014Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
CY2014Q1 dei Document Period End Date
DocumentPeriodEndDate
2014-03-31
CY2014Q1 dei Document Type
DocumentType
10-Q
CY2014Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001043961
CY2014Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
7353695 shares
CY2014Q1 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2014Q1 dei Entity Registrant Name
EntityRegistrantName
TRANSGENOMIC INC

Files In Submission

Name View Source Status
0001043961-14-000006-index-headers.html Edgar Link pending
0001043961-14-000006-index.html Edgar Link pending
0001043961-14-000006.txt Edgar Link pending
0001043961-14-000006-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tbio-20140331.xml Edgar Link completed
tbio-20140331.xsd Edgar Link pending
tbio-20140331x10q.htm Edgar Link pending
tbio-20140331_cal.xml Edgar Link unprocessable
tbio-20140331_def.xml Edgar Link unprocessable
tbio-20140331_lab.xml Edgar Link unprocessable
tbio-20140331_pre.xml Edgar Link unprocessable
tbio-ex311_20140331x10q.htm Edgar Link pending
tbio-ex312_20140331x10q.htm Edgar Link pending
tbio-ex321_20140331x10q.htm Edgar Link pending
tbio-ex322_20140331x10q.htm Edgar Link pending